Skip to main content

Healthcare investors hope to cash in on federal stimulus money

By Patty Enrado

Edits to this story were made on April 1, 2009.

Investors focused on healthcare information technology continue to face a  bleak scenario of low company valuations, but they’re optimistic about healthcare opportunities in the federal stimulus package.

Investment firms are scrutinizing the federal stimulus package closely, seeking new opportunities to raise capital, according to a panel addressing healthcare IT investment trends and outlooks at the Health Tech Investment Forum, held Tuesday in San Francisco.

Thomas, McNerney & Partners is exploring whether its companies can benefit from the federal stimulus package for healthcare IT, said partner Karen Boezi. Her firm doesn't invest in hospital systems, but there may be opportunities for the $2 billion set aside for electronic medical record connectivity, she said.

California could get approximately 10 percent of the $2 billion set aside for healthcare IT infrastructure from the federal stimulus package, according to Kathryn Lowell, deputy secretary for Health Systems & Life Sciences at the state of California’s Business, Transportation & Housing Agency.

Lowell said this specific funding would require the state to develop a governance-level entity to oversee healthcare IT. With seven operational regional health information organizations, the state already has healthcare IT infrastructure to leverage, she said.

"The state is grappling with how to govern healthcare IT at the state level," Lowell said, but added, "We will develop state standards that can interface with federal-level standards."

Bijan Salehizadeh, MD, general partner at Highland Capital Partners, said the legislative language is unclear as to whether the federal stimulus funds will be relevant for his companies or even if his companies will be eligible to receive these funds.

"It may set up the next generation of companies," Salehizadeh offered.

Lisa Suennen, co-founder and managing member of the Psilos Group, which funds mid- to later-stage companies in healthcare IT, services and medical technology, doesn’t see any short-term benefit for her companies, although there may be benefits in the long term. “If the smaller companies don’t learn how to interact with the government, then the money will only benefit the big companies,” she said.